<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-ijms-22-00248">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhao</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Piao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Shao</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling</article-title>
  <source>Biomed. Pharmacother.</source>
  <year>2020</year>
  <volume>127</volume>
  <fpage>110151</fpage>
  <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110151</pub-id>
  <pub-id pub-id-type="pmid">32559840</pub-id>
 </element-citation>
</ref>
